Mirae Asset Global Etfs Holdings Ltd. Biocryst Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 113,527 shares of BCRX stock, worth $929,786. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,527Holding current value
$929,786% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCRX
# of Institutions
260Shares Held
173MCall Options Held
397KPut Options Held
444K-
Black Rock Inc. New York, NY20MShares$163 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.8MShares$154 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.6MShares$103 Million1.06% of portfolio
-
State Street Corp Boston, MA9.35MShares$76.6 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.83MShares$72.3 Million4.25% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.52B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...